AK Medical Holdings
Market Cap
HK$5.1b
Last Updated
2019/08/18 13:01 UTC
Data Sources
Company Financials +
Executive Summary
AK Medical Holdings Limited, an investment holding company, designs, develops, produces, and markets orthopedic joint implants and related products under the AK Medical brand primarily in the People’s Republic of China.
Snowflake
Fundamentals
Exceptional growth potential with flawless balance sheet.
Risks
- AK Medical Holdings has significant price volatility in the past 3 months.
- AK Medical Holdings is covered by less than 3 analysts.
Similar Companies
Share Price & News
How has AK Medical Holdings's share price performed over time and what events caused price changes?
Latest Share Price and Events
Market Performance
7 Day Return
3.8%
SEHK:1789
0.6%
HK Medical Equipment
-0.6%
HK Market
1 Year Return
7.9%
SEHK:1789
-6.4%
HK Medical Equipment
-9.8%
HK Market
1789 outperformed the Medical Equipment industry which returned -6.4% over the past year.
1789 outperformed the Market in Hong Kong which returned -9.8% over the past year.
Share holder returns
| 1789 | Industry | Market | |
|---|---|---|---|
| 7 Day | 3.8% | 0.6% | -0.6% |
| 30 Day | 5.2% | -2.4% | -8.8% |
| 90 Day | 34.7% | -5.0% | -8.4% |
| 1 Year | 8.9%7.9% | -5.4%-6.4% | -6.5%-9.8% |
| 3 Year | n/a | 4.6%1.2% | 12.8%1.6% |
| 5 Year | n/a | -13.1%-17.5% | 7.2%-10.6% |
Price Volatility Vs. Market
How volatile is AK Medical Holdings's share price compared to the market and industry in the last 5 years?
Simply Wall St News
3 weeks ago | Simply Wall St
AK Medical Holdings Limited (HKG:1789): Is It A Good Long Term Opportunity?1 month ago | Simply Wall St
Here's What AK Medical Holdings Limited's (HKG:1789) ROCE Can Tell Us1 month ago | Simply Wall St
What Kind Of Shareholders Own AK Medical Holdings Limited (HKG:1789)?Valuation
Is AK Medical Holdings undervalued based on future cash flows and its price relative to the stock market?
>50%
Discount to future cash flow value
Intrinsic Value Based on Future Cash Flows
AK Medical Holdings's share price is below the future cash flow value, and at a moderate discount (> 20%).
AK Medical Holdings's share price is below the future cash flow value, and at a substantial discount (> 40%).
Price Based on Earnings
AK Medical Holdings is overvalued based on earnings compared to the HK Medical Equipment industry average.
AK Medical Holdings is overvalued based on earnings compared to the Hong Kong market.
Price Based on Expected Growth
AK Medical Holdings is poor value based on expected growth next year.
Price Based on Value of Assets
AK Medical Holdings is overvalued based on assets compared to the HK Medical Equipment industry average.
Next Steps
Future Growth
How is AK Medical Holdings expected to perform in the next 1 to 3 years based on estimates from 2 analysts?
26.9%
Forecasted annual earnings growth
Earnings and Revenue Growth Estimates
Future Annual Growth Analysis
AK Medical Holdings's revenue is expected to grow significantly at over 20% yearly.
AK Medical Holdings's earnings are expected to grow significantly at over 20% yearly.
AK Medical Holdings's revenue growth is expected to exceed the Hong Kong market average.
AK Medical Holdings's earnings growth is expected to exceed the Hong Kong market average.
AK Medical Holdings's earnings growth is expected to exceed the low risk savings rate of 2%.
Earnings per Share Growth Estimates
Future Return on Equity
AK Medical Holdings is expected to efficiently use shareholders’ funds in the future (Return on Equity greater than 20%).
Next Steps
Past Performance
How has AK Medical Holdings performed over the past 5 years?
23.6%
Historical annual earnings growth
Earnings and Revenue History
Past Earnings Growth Analysis
AK Medical Holdings has delivered over 20% year on year earnings growth in the past 5 years.
AK Medical Holdings's 1-year earnings growth exceeds its 5-year average (37.5% vs 23.6%)
AK Medical Holdings's earnings growth has exceeded the HK Medical Equipment industry average in the past year (37.5% vs 19%).
Return on Equity
AK Medical Holdings has not efficiently used shareholders’ funds last year (Return on Equity less than 20%).
Return on Assets
AK Medical Holdings used its assets more efficiently than the HK Medical Equipment industry average last year based on Return on Assets.
Return on Capital Employed
AK Medical Holdings's use of capital deteriorated last year versus 3 years ago (Return on Capital Employed).
Next Steps
Financial Health
How is AK Medical Holdings's financial position?
Financial Position Analysis
AK Medical Holdings is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
AK Medical Holdings's cash and other short term assets cover its long term commitments.
Debt to Equity History and Analysis
AK Medical Holdings has no debt.
AK Medical Holdings has not taken on any debt in the past 5 years.
AK Medical Holdings has no debt, it does not need to be covered by operating cash flow.
AK Medical Holdings has no debt, therefore coverage of interest payments is not a concern.
Balance Sheet
High level of physical assets or inventory.
AK Medical Holdings has no debt, it does not need to be covered by short term assets.
Next Steps
Dividend
What is AK Medical Holdings's current dividend yield, its reliability and sustainability?
1.71%
Expected Dividend Yield
Dividend Yield and Payments Analysis
AK Medical Holdings's pays a lower dividend yield than the bottom 25% of dividend payers in Hong Kong (2.29%).
AK Medical Holdings's dividend is below the markets top 25% of dividend payers in Hong Kong (6.26%).
AK Medical Holdings is not paying a notable dividend for Hong Kong, therefore no need to check if the payments are stable.
AK Medical Holdings is not paying a notable dividend for Hong Kong, therefore no need to check if the payments are increasing.
Current Payout to Shareholders
No need to calculate the sustainability of AK Medical Holdings's dividends as it is not paying a notable one for Hong Kong.
Future Payout to Shareholders
Dividends after 3 years are expected to be well covered by earnings (3.2x coverage).
Next Steps
Management
What is the CEO of AK Medical Holdings's salary, the management and board of directors tenure and is there insider trading?
3.3yrs
Average management tenure
CEO
Zhijiang Li (51yo)
CN¥1,375,000
Compensation
Mr. Zhijiang Li serves as Chairman and Chief Executive Officer at AK Medical Holdings Limited. Mr. Li is responsible for the overall strategic planning and development of at AK Medical Holdings Limited. Mr ...
CEO Compensation Analysis
Zhijiang's remuneration is lower than average for companies of similar size in Hong Kong.
Zhijiang's compensation has increased by more than 20% in the past year whilst earnings grew less than 20%.
Management Age and Tenure
3.3yrs
Average Tenure
50.5yo
Average Age
The tenure for the AK Medical Holdings management team is about average.
Board Age and Tenure
3.3yrs
Average Tenure
51yo
Average Age
The tenure for the AK Medical Holdings board of directors is about average.
Insider Trading
No 3 month open market individual insider trading information.
Recent Insider Transactions
| Entity | Company |
| Shares | 574,000 |
| Max Price | HK$3.52 |
| Entity | Individual |
| Role | Senior VP & Executive Director Member of the Board of Directors |
| Shares | 270,000 |
| Max Price | HK$5.23 |
| Entity | Individual |
| Role | Senior VP & Executive Director Member of the Board of Directors |
| Shares | 668,000 |
| Max Price | HK$5.25 |
| Entity | Individual |
| Role | Senior VP & Executive Director Member of the Board of Directors |
| Shares | 676,000 |
| Max Price | HK$5.43 |
Ownership Breakdown
Management Team
Rita Li (54yo)
Joint Company Secretary
- Tenure: 3.3yrs
Zhijiang Li (51yo)
Chairman & CEO
- Compensation: CN¥1.38m
Bin Zhang (51yo)
Senior VP & Executive Director
- Tenure: 3.3yrs
- Compensation: CN¥446.00k
Chaoyang Zhang (50yo)
Senior VP & Executive Director
- Tenure: 3.3yrs
- Compensation: CN¥1.16m
Xiaohong Zhao (41yo)
CFO & Executive Director
- Tenure: 3.3yrs
- Compensation: CN¥1.65m
Yu Han (36yo)
Joint Company Secretary
- Tenure: 3.3yrs
Weiping Zhang (68yo)
Chief Engineer of Ak Medical Beijing
- Tenure: 10.7yrs
Sun Hongbo (37yo)
Head of Production Centre of AK Medical Beijing
- Tenure: 2.7yrs
Board Members
David Wang (58yo)
Non-Executive Director
- Tenure: 3.5yrs
David Li (55yo)
Independent Non-Executive Director
- Tenure: 1.8yrs
- Compensation: CN¥152.00k
Roy Kong (43yo)
Independent Non-Executive Director
- Tenure: 1.8yrs
- Compensation: CN¥152.00k
Zhijiang Li (51yo)
Chairman & CEO
- Tenure: 3.3yrs
- Compensation: CN¥1.38m
Gengting Dang (84yo)
Independent Non-Executive Director
- Tenure: 1.8yrs
- Compensation: CN¥150.00k
Xiaohong Zhao (41yo)
CFO & Executive Director
- Tenure: 3.5yrs
- Compensation: CN¥1.65m
Bin Zhang (51yo)
Senior VP & Executive Director
- Tenure: 4.1yrs
- Compensation: CN¥446.00k
Chaoyang Zhang (50yo)
Senior VP & Executive Director
- Tenure: 4.1yrs
- Compensation: CN¥1.16m
Wenming Li (45yo)
Non-Executive Director
- Tenure: 3.3yrs
- Compensation: CN¥150.00k
Company Information
AK Medical Holdings Limited's company bio, employee growth, exchange listings and data sources
Key Information
- Name: AK Medical Holdings Limited
- Ticker: 1789
- Exchange: SEHK
- Founded: 2003
- Industry: health care equipment
- Sector: healthcare
- Market Cap: HK$5.105b
- Shares outstanding: 1.04b
- Website: Click here
Number of Employees
Location
- AK Medical Holdings Limited
- XingYe Mansion
- 2nd Floor
- Beijing
- 102200
- China
Listings
| Ticker | Exchange | Primary Security | Security Type | Country | Currency | Listed on |
|---|---|---|---|---|---|---|
| 1789 | SEHK (The Stock Exchange of Hong Kong Ltd.) | Yes | Ordinary Shares | HK | HKD | Dec 2017 |
Biography
AK Medical Holdings Limited, an investment holding company, designs, develops, produces, and markets orthopedic joint implants and related products under the AK Medical brand primarily in the People’s Repu ...
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2019/08/18 13:01 |
| End of Day Share Price | 2019/08/16 00:00 |
| Earnings | 2018/12/31 |
| Annual Earnings | 2018/12/31 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.